Area of Specialization
Cardiology. Cardiac imaging.

Contact Dr. Reza Banifatemi
Patient Portal

705 Maple Road
Williamsville, NY 14221
Map/Directions

Special Interests
Valvular heart disease, Echocardiography, preventative cardiology.

Education
POSTGRADUATE TRAINING
Drexel University College of Medicine
Cardiology Fellowship
Philadelphia, PA
July 2008-June 2011
 
Chief Cardiology Fellow, July 2009-July 2010
 
Drexel University College of Medicine
Internship and Residency in Internal Medicine
Philadelphia, PA
Aug 2001–Aug 2004

EDUCATION
Pecs University School of Medicine, Pecs, Hungary
Sept 1991 – August 1997
M.D. Sept 1997

FACULTY APPOINTMENTS                   
Assistant Professor of Medicine
Department of Medicine
Drexel University College of Medicine
Aug 2004 – Dec 2007

Specialty Boards and Certifications
     •  Board Certified in Internal Medicine, 2004
     •  Board Certified in Cardiovascular diseases, 2011
     •  Board Certified in Nuclear Cardiology, 2010
     •  Board Certified in Echocardiography, 2014

Professional Memberships
      •  American College of Cardiology F.A.C.C
      •  American Society of Echocardiography, Diplomate
      •  American Society of Nuclear Cardiology

Awards and Honors
      •  2018, 2017, 2016 Western New York Top Doctor, Cardiology. Castle Connolly. 
      •  Dean’s Special Award for Excellence in clinical teaching Class of 2007
      •  Ronald F Pennock Award for Excellence in Education of Medical Residents Drexel University College of Medicine

Research
Systolic Augmentation of Continuous Aortic Regurgitation: A Novel Marker of Increased Fractional Shortening and Flow in HeartMate II Supported Patients
A Agarwal, M Padmalingam, R Mohan, R Banifatemi, J Fontaine, S Hankins, H Eisen, J Plehn
The Journal of Heart and Lung Transplantation, Volume 30, Issue 4
Elsevier
 
Principal Investigator:
 
Orexigen: NB-CVOT: A Multicenter, Randomized, Double-Blind, Placebo-
Controlled Study Assessing the Occurrence of Major Adverse Cardiovascular
Events (MACE) in Overweight and Obese Subjects With Cardiovascular Risk Factors Receiving Naltrexone SR/Bupropion SR  2012
 
Astra Zeneca: A randomized, double-blind, parallel group, multicentre phase IIIb study to compare ticagrelor with clopidogrel treatment on the risk of cardiovascular death, myocardial infarction and ischemic stroke in patients with established Peripheral Artery Disease. EUCLID (Examining Use of tiCagreL or In paD)  2012